Cizzle Biotechnology Holdings Plc

LSE:CIZ.L

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🌿 Fertilizers

Location

United Kingdom

Market Cap

USD 8.53 M

Share Price

USD 0.02

Avg Daily Volume

1,257,036

Change (1 day)

-0.13%

Change (1 year)

12.89%

Change (YTD)

17.90%

Cizzle Biotechnology Holdings Plc Revenue for the year ending December 31, 2023

Cizzle Biotechnology Holdings Plc Revenue is NA for the year ending December 31, 2023. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Cizzle Biotechnology Holdings Plc Revenue for the year ending December 31, 2022 was USD 0.00.
Cizzle Biotechnology Holdings Plc Revenue for the year ending December 31, 2021 was USD 0.00.
Cizzle Biotechnology Holdings Plc Revenue for the year ending December 31, 2020 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

LSE: CIZ.L

Cizzle Biotechnology Holdings Plc

CEO	Dr. Allan John Syms
IPO Date	May 14, 2021
Location	United Kingdom
Headquarters	60 Gracechurch Street
Employees	4
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 🔬 Chemicals & Advanced Materials 🌿 Fertilizers

Description

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Similar companies

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

Agilent Technologies, Inc.

USD 115.56

0.03%

Qiagen N.V.

USD 46.76

0.45%

Aurobindo Pharma Limited

USD 12.66

1.46%

Repligen Corporation

USD 118.85

1.11%

Bruker Corporation

USD 38.08

-0.91%

Yuhan Corporation

USD 75.65

3.64%

Pharmaron Beijing Co., Ltd.

USD 1.95

0.66%

Bachem Holding AG

USD 71.24

1.58%

Siegfried Holding AG

USD 115.48

0.37%

Cohance Lifesciences Limited

USD 11.35

-0.68%

Gan & Lee Pharmaceuticals.

USD 7.48

0.56%

Bloomage BioTechnology Corporation Limited

USD 7.11

1.51%

Syngene International Limited

USD 7.29

0.73%

Metsera, Inc.

USD 29.60

6.82%

Jafron Biomedical Co.,Ltd.

USD 2.94

1.21%

Anhui Anke Biotechnology (Group) Co., Ltd.

USD 1.15

-0.33%

Beijing Hotgen Biotech Co., Ltd.

USD 18.59

-1.19%

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

USD 2.00

-0.57%

Sansure Biotech Inc.

USD 2.83

2.01%

Changzhou Qianhong Biopharma CO.,LTD

USD 1.20

2.53%

Novo Nordisk A/S

USD 73.32

-2.33%

AbbVie Inc.

USD 185.30

-0.10%

Roche Holding AG

USD 336.78

-0.52%

Abbott Laboratories

USD 132.99

0.44%

Novartis AG

USD 115.96

-0.50%

AstraZeneca PLC

USD 140.24

-1.30%

Merck & Co., Inc.

USD 79.06

-0.29%

Amgen Inc.

USD 289.33

-0.10%

Boston Scientific Corporation

USD 101.30

-0.07%

Thermo Fisher Scientific Inc.

USD 397.88

1.35%

Danaher Corporation

USD 196.39

1.00%

Pfizer Inc.

USD 23.97

0.38%

Gilead Sciences, Inc.

USD 108.50

0.46%

Sanofi

USD 95.88

0.36%

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

Bristol-Myers Squibb Company

USD 46.86

0.04%

GSK plc

USD 18.89

-2.25%

CSL Limited

USD 154.82

0.08%

Siemens Healthineers AG

USD 53.26

0.96%

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

Samsung Biologics Co.,Ltd.

USD 737.62

2.27%

Becton, Dickinson and Company

USD 168.42

-0.10%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB SA

USD 181.46

0.14%

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

StockViz Staff

June 23, 2025

Any question? Send us an email